Improving brain function in Alzheimer's disease by enhancing new neurons
Enhancing adult-born neurons to restore brain functions in Alzheimer's disease
This study is exploring ways to help people with Alzheimer's disease grow new brain cells, which could improve their memory and reduce feelings of anxiety, by using special techniques to stimulate a specific part of the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10906982 on NIH RePORTER |
What this research studies
This research investigates how to enhance the production of new neurons in the brains of individuals with Alzheimer's disease, which is often associated with memory loss and emotional difficulties. The approach involves stimulating a specific brain region to promote the growth and development of these neurons, which may help restore cognitive and emotional functions. By using advanced techniques like optogenetics and chemogenetics, the researchers aim to understand how these enhanced neurons can improve memory and reduce anxiety in Alzheimer's patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with Alzheimer's disease and experience cognitive and emotional challenges.
Not a fit: Patients with early-stage Alzheimer's disease or those without significant cognitive or emotional symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve memory and emotional well-being for patients with Alzheimer's disease.
How similar studies have performed: Previous studies have shown promising results in enhancing neurogenesis in healthy brains, but this approach in Alzheimer's disease is still being explored and is considered novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Song, Juan — Univ of North Carolina Chapel Hill
- Study coordinator: Song, Juan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.